Charles River Laboratories International Inc C.CRL

Primary Symbol: CRL

Technology Scientific & Technical Instruments

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

NYSE:CRL - Post by User

Charles River Laboratories International Inc

Bullboard Posts

Comment by Ticklel1ston Sep 03, 2019 2:06pm

94 Views

Post# 30091171

RE:RE:950 million pie

So, if I'm reading this right, CRL had to be selected to take part by earning their way into the consortium and then get the opportunity to work with other leaders in healthcare, communications, natural resources, technology and transportation. To advance CRL data programs, CRl will get funding and financial backing and tech support.

Nice

Bullboard Posts

Critical raw materials pioneer drives Europe’s clean energy transition